ask="9.45"
ask_size="6500"
average_daily_volume="335466"
bid="6.75"
bid_size="200"
book_value="3.69"
change="+0.40"
change_from_200_day_moving_average="-3.65"
change_from_50_day_moving_average="-2.94"
change_from_52_week_high="-7.80"
change_From_52_week_low="2.92"
change_in_percent="+6.25%"
close="6.80"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.17"
ebitda="-38.95M"
eps_estimate_current_year="-2.14"
eps_estimate_next_quarter="-0.52"
eps_estimate_next_year="-2.05"
ex_dividend_date="N/A"
float_shares="16060000"
high="6.80"
high_52_weeks="14.60"
last_trade_date="2/17/2017"
last_trade_price="6.80"
last_trade_size="18151"
last_trade_time="4:00pm"
low="6.40"
low_52_weeks="3.88"
market_capitalization="121.35M"
moving_average_200_day="10.45"
moving_average_50_day="9.74"
name="Stemline Therapeutics
Inc."
notes="N/A"
one_year_target_price="25.50"
open="6.45"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-34.94%"
percent_change_from_50_day_moving_average="-30.18%"
percent_change_from_52_week_high="-53.42%"
percent_change_from_52_week_low="+75.26%"
previous_close="6.40"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.74"
price_per_sales="120.53"
revenue="947604.00"
shares_outstanding="17846000"
short_ratio="1.96"
stock_exchange="NCM"
symbol="STML"
volume="207347"
weeks_range_52="3.88 - 14.60"
